{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:16:09Z","timestamp":1772165769009,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To present clinical presentations, histological-pathological patterns, clinical T stage, divergent treating methods, and outcomes of primary adenoid cystic carcinoma (ACC) of the lacrimal gland in a Chinese population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This case series included patients with primary lacrimal gland adenoid cystic carcinoma treated at a Chinese hospital between 2003 and 2014. An exploratory multivariate Cox regression analysis was performed to evaluate the prognostic impact of clinical T-stage. Subsequently, Kaplan\u2013Meier survival analysis was conducted, stratifying patients by T-stage (T4 vs. T1\u2013T3) and by surgical approach among T4 patients, to assess the influence of tumor stage and surgical management on disease-free survival outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 38 patients included 16 men and 22 women with a median age of 46.3 years were enrolled. Sixteen patients (42.11%) had local recurrence, while nineteen patients (50%) had distant metastasis at the time of presentation. Twelve patients (31.58%) were in T1-T3 stage and twenty-six (68.42%) were in T4 stage. Nineteen patients (73.08%) in the T4 stage exhibited a predominantly solid-basaloid pattern, and only three (25%) in T1-T3 stage had a predominantly solid-basaloid pattern histological pattern. Median DFS for the entire cohort was 29.0 months (95% CI, 19.0\u201339.0), and median survival after metastasis was 7.0 months (95% CI, 3.0\u20139.0). After adjustment for covariates, T4 stage remained independently associated with significantly shorter DFS (HR\u2009=\u20094.46, 95% CI: 1.40-14.21,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.011). A significant difference in DFS was observed between the T1\u2013T3 and T4 groups (log-rank\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003). Meanwhile, no significant difference in disease-free survival was observed between T4 patients undergoing globe-preserving surgery and eye-sparing approaches (log-rank\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.297).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this Chinese cohort, the solid-basaloid pattern correlated strongly with advanced T4 disease and aggressive behavior. Kaplan\u2013Meier and multivariate Cox analyses consistently demonstrated that T4 stage was independently associated with significantly poorer DFS. For T4 patients, DFS did not differ significantly between exenteration and globe-preserving surgery when combined with radiotherapy, suggesting that eye-sparing approaches may be viable in advanced cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-025-15426-9","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T05:06:21Z","timestamp":1765515981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Histological-pathological and clinical T stage of primary adenoid cystic carcinoma of the lacrimal gland in a Chinese population"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiayi","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiqin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"3","key":"15426_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.oraloncology.2004.12.004","volume":"41","author":"AD Rapidis","year":"2005","unstructured":"Rapidis AD, et al. Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature. Oral Oncol. 2005;41(3):328\u201335. https:\/\/doi.org\/10.1016\/j.oraloncology.2004.12.004.","journal-title":"Oral Oncol"},{"issue":"1","key":"15426_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/s0161-6420(85)34081-2","volume":"92","author":"DA Lee","year":"1985","unstructured":"Lee DA, et al. A clinicopathologic study of primary adenoid cystic carcinoma of the lacrimal gland. Ophthalmology. 1985;92(1):128\u2013. https:\/\/doi.org\/10.1016\/s0161-6420(85)34081-2. 34.","journal-title":"Ophthalmology"},{"issue":"5","key":"15426_CR3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1001\/archophthalmol.2011.1606","volume":"130","author":"T El-Sawy","year":"2012","unstructured":"El-Sawy T, et al. Prognostic accuracy of the seventh edition vs sixth edition of the American joint committee on cancer tumor classification for adenoid cystic carcinoma of the lacrimal gland. Arch Ophthalmol. 2012;130(5):664\u20136. https:\/\/doi.org\/10.1001\/archophthalmol.2011.1606.","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"15426_CR4","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.ophtha.2013.01.027","volume":"120","author":"DT Tse","year":"2013","unstructured":"Tse DT, et al. Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma. Ophthalmology. 2013;120(7):1313\u201323. https:\/\/doi.org\/10.1016\/j.ophtha.2013.01.027.","journal-title":"Ophthalmology"},{"issue":"10","key":"15426_CR5","doi-asserted-by":"publisher","first-page":"Xc05","DOI":"10.7860\/jcdr\/2015\/14452.6669","volume":"9","author":"V Roshan","year":"2015","unstructured":"Roshan V, et al. Adjuvant radiotherapy with Three-Dimensional conformal radiotherapy of lacrimal gland adenoid cystic carcinoma. J Clin Diagn Res. 2015;9(10):Xc05\u20137. https:\/\/doi.org\/10.7860\/jcdr\/2015\/14452.6669.","journal-title":"J Clin Diagn Res"},{"issue":"16","key":"15426_CR6","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1002\/cncr.26740","volume":"118","author":"N Li","year":"2012","unstructured":"Li N, et al. A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and end results registry. Cancer. 2012;118(16):3945\u201353. https:\/\/doi.org\/10.1002\/cncr.26740.","journal-title":"Cancer"},{"issue":"3","key":"15426_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/bf02484288","volume":"17","author":"M Terasaki","year":"2000","unstructured":"Terasaki M, et al. High-grade adenoid cystic carcinoma originating from the lacrimal gland. Brain Tumor Pathol. 2000;17(3):159\u201363. https:\/\/doi.org\/10.1007\/bf02484288.","journal-title":"Brain Tumor Pathol"},{"issue":"3","key":"15426_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jmir.2014.01.002","volume":"45","author":"S Stanford","year":"2014","unstructured":"Stanford S, et al. Adenoid cystic carcinoma of the lacrimal gland: A case report with a review of the literature. J Med Imaging Radiat Sci. 2014;45(3):323\u20136. https:\/\/doi.org\/10.1016\/j.jmir.2014.01.002.","journal-title":"J Med Imaging Radiat Sci"},{"issue":"5","key":"15426_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.5935\/0004-2749.20160095","volume":"79","author":"A Ramos","year":"2016","unstructured":"Ramos A, et al. Adenoid cystic carcinoma of the lacrimal sac: case report. Arq Bras Oftalmol. 2016;79(5):333\u20135. https:\/\/doi.org\/10.5935\/0004-2749.20160095.","journal-title":"Arq Bras Oftalmol"},{"issue":"1","key":"15426_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01.Iop.0000105518.72611.4f","volume":"20","author":"B Esmaeli","year":"2004","unstructured":"Esmaeli B, et al. Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland. Ophthalmic Plast Reconstr Surg. 2004;20(1):22\u20136. https:\/\/doi.org\/10.1097\/01.Iop.0000105518.72611.4f.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"15426_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.18240\/ijo.2024.01.22","volume":"17","author":"HH Yan","year":"2024","unstructured":"Yan HH, Liu R, Wang N, Xu LY, Guo QH, Li J, et al. Treatment of lacrimal gland adenoid cystic carcinoma: a systematic review and Meta-analysis. Int J Ophthalmol. 2024;17(1):164\u201372. PMID: 38239951IF: 1.8 Q3 B4; PMCID: PMC10754659IF: 1.8 Q3 B4.","journal-title":"Int J Ophthalmol"},{"issue":"8","key":"15426_CR12","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.5858\/133.8.1268","volume":"133","author":"J Rootman","year":"2009","unstructured":"Rootman J, White VA. Changes in the 7th edition of the AJCC TNM classification and recommendations for pathologic analysis of lacrimal gland tumors. Arch Pathol Lab Med. 2009;133(8):1268\u201371. https:\/\/doi.org\/10.5858\/133.8.1268.","journal-title":"Arch Pathol Lab Med"},{"key":"15426_CR13","doi-asserted-by":"publisher","first-page":"834704","DOI":"10.3389\/fonc.2022.834704","volume":"12","author":"JC Yang","year":"2022","unstructured":"Yang JC, et al. Afatinib for the treatment of Non-Small cell lung cancer harboring uncommon EGFR mutations: an updated database of 1023 cases brief report. Front Oncol. 2022;12:834704. https:\/\/doi.org\/10.3389\/fonc.2022.834704.","journal-title":"Front Oncol"},{"issue":"2","key":"15426_CR14","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1007\/s12070-023-04426-5","volume":"76","author":"VJ Bahl","year":"2024","unstructured":"Bahl VJ, Bahl A. Adenoid cystic cancer of the lacrimal gland: management aspects and treatment outcomes. Indian J Otolaryngol Head Neck Surg. 2024;76(2):2158\u201361. https:\/\/doi.org\/10.1007\/s12070-023-04426-5. Epub 2023 Dec 21. PMID: 38566663IF: 0.4 Q4 B4; PMCID: PMC10982151IF: 0.4 Q4 B4.","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"issue":"1","key":"15426_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1177\/11206721241249503","volume":"35","author":"X Zhou","year":"2025","unstructured":"Zhou X, Feng Y, Yang Y, Zong C, Yu Y, Zhu T, et al. Clinical and histopathological factors for recurrence and metastasis in lacrimal gland adenoid cystic carcinoma in Chinese patients. Eur J Ophthalmol. 2025;35(1):375\u201382. Epub 2024 Apr 30. PMID: 38689460IF: 1.4 Q3 B4.","journal-title":"Eur J Ophthalmol"},{"issue":"11","key":"15426_CR16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3390\/dj11110262","volume":"11","author":"EF de Morais","year":"2023","unstructured":"de Morais EF, de Farias Morais HG, de Almeida Freitas R, Coletta RD. Prognostic significance of histopathological parameters for salivary gland adenoid cystic carcinoma. Dent J (Basel). 2023;11(11):262. https:\/\/doi.org\/10.3390\/dj11110262. PMID: 37999026IF: 3.1 Q1 B3; PMCID: PMC10670021IF: 3.1 Q1 B3.","journal-title":"Dent J (Basel)"},{"key":"15426_CR17","doi-asserted-by":"crossref","unstructured":"American Joint Committee on Cancer: AJCC Cancer Staging Manual. 7th ed16. Font RL, Smith SL, Bryan RG. Malignant epithelial tumors of the lacrimal gland: a clinicopathologic study of 21 cases. Archives of ophthalmology (Chicago, Ill. 1960). 1998;116(5):613-6.","DOI":"10.1001\/archopht.116.5.613"},{"issue":"8","key":"15426_CR18","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3346\/jkms.2017.32.8.1351","volume":"32","author":"SK Park","year":"2017","unstructured":"Park SK, Park J, Kim HU, Yun SK. Sebaceous carcinoma: clinicopathologic analysis of 29 cases in a tertiary hospital in Korea. J Korean Med Sci. 2017;32(8):1351\u20139. https:\/\/doi.org\/10.3346\/jkms.2017.32.8.1351. PMID: 28665073IF: 2.3 Q2 B4; PMCID: PMC5494336IF: 2.3 Q2 B4.","journal-title":"J Korean Med Sci"},{"issue":"5","key":"15426_CR19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1001\/archopht.116.5.613","volume":"116","author":"RL Font","year":"1998","unstructured":"Font RL, et al. Malignant epithelial tumors of the lacrimal gland: a clinicopathologic study of 21 cases. Arch Ophthalmol. 1998;116(5):613\u20136. https:\/\/doi.org\/10.1001\/archopht.116.5.613.","journal-title":"Arch Ophthalmol"},{"issue":"18","key":"15426_CR20","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1002\/cncr.27408","volume":"118","author":"CL Ellington","year":"2012","unstructured":"Ellington CL, et al. Adenoid cystic carcinoma of the head and neck: incidence and survival trends based on 1973\u20132007 Surveillance, Epidemiology, and end results data. Cancer. 2012;118(18):4444\u201351. https:\/\/doi.org\/10.1002\/cncr.27408.","journal-title":"Cancer"},{"issue":"1","key":"15426_CR21","first-page":"3","volume":"17","author":"JE Wright","year":"1982","unstructured":"Wright JE. Factors affecting the survival of patients with lacrimal gland tumours. Can J Ophthalmol. 1982;17(1):3\u20139.","journal-title":"Can J Ophthalmol"},{"key":"15426_CR22","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.ophtha.2008.12.049","volume":"116","author":"SM Ahmad","year":"2009","unstructured":"Ahmad SM, Esmaeli B, Williams M, Nguyen J, Fay A, Woog J, et al. American joint committee on cancer classifcation predicts outcome of patients with lacrimal gland adenoid cystic carcinoma. Ophthalmology. 2009;116:1210\u20135.","journal-title":"Ophthalmology"},{"issue":"1","key":"15426_CR23","first-page":"58","volume":"49","author":"L Zhang","year":"2013","unstructured":"Zhang L, Zhang H, Song GX, Lin TT, Xu GC, Zhu LM. [The expression of MMP-2 and MMP-9 in adenoid cystic carcinoma of lacrimal gland]. Zhonghua Yan Ke Za Zhi. 2013;49(1):58\u201363. Chinese. PMID: 23601468IF: NA NA NA.","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"1","key":"15426_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12886-019-1110-5","volume":"19","author":"J Yang","year":"2019","unstructured":"Yang J, et al. Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma. BMC Ophthalmol. 2019;19(1):125. https:\/\/doi.org\/10.1186\/s12886-019-1110-5.","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"15426_CR25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/iop.0000000000000877","volume":"34","author":"J Han","year":"2018","unstructured":"Han J, et al. Long-Term outcomes of Eye-Sparing surgery for adenoid cystic carcinoma of lacrimal gland. Ophthalmic Plast Reconstr Surg. 2018;34(1):74\u20138. https:\/\/doi.org\/10.1097\/iop.0000000000000877.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"15426_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13014-020-01601-8","volume":"15","author":"YH Lin","year":"2020","unstructured":"Lin YH, et al. Outcomes in patients with lacrimal gland carcinoma treated with definitive radiotherapy or eye-sparing surgery followed by adjuvant radiotherapy. Radiat Oncol. 2020;15(1):156. https:\/\/doi.org\/10.1186\/s13014-020-01601-8.","journal-title":"Radiat Oncol"},{"issue":"1","key":"15426_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/iop.0000000000000531","volume":"32","author":"KI Woo","year":"2016","unstructured":"Woo KI, et al. Management of lacrimal gland carcinoma: lessons from the literature in the past 40 years. Ophthalmic Plast Reconstr Surg. 2016;32(1):1\u201310. https:\/\/doi.org\/10.1097\/iop.0000000000000531.","journal-title":"Ophthalmic Plast Reconstr Surg"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15426-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15426-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15426-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:16:32Z","timestamp":1769170592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15426-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15426"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15426-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7131396\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. The study protocol was reviewed and approved by the Medical Ethics Review Committee of Changzhi People\u2019s Hospital affiliated with Changzhi Medical College (Approval ID: 2025K040, approved on June 24, 2025). Written informed consent was obtained from all participants prior to inclusion. As this was a retrospective case series based on existing records, formal trial registration was not required under institutional and national research guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}